** ASX-listed shares of AVITA Medical Inc fall as much as 16.2% to A$3.770, their lowest since Jan 8
** Stock set for worst day since Oct 3, if losses hold
** Co expects March-qtr commercial revenue between $11 mln and $11.3 mln, lower than previous forecast of $14.8 mln to $15.6 mln
** Says the downward revision due to slower-than-expected conversion rate of new accounts for expanded label of full-thickness skin defects
** AVH top loser on ASX All Ordinaries index
** As of last close, stock up 4.9% this year
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments